52 related articles for article (PubMed ID: 27444307)
1. Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis.
Sun Z; Yang Y; Lin B; Huang Y; Zhou R; Yang C; Li Y; Huang S; Liu X
BMC Ophthalmol; 2023 Nov; 23(1):473. PubMed ID: 37990182
[TBL] [Abstract][Full Text] [Related]
2. SUBRETINAL FLUID ASSOCIATED WITH DRUSENOID PIGMENT EPITHELIAL DETACHMENT.
Cho HJ; Jeon YJ; Yoon W; Lee J; Kim J; Kim CG; Kim JW
Retina; 2023 Aug; 43(8):1274-1281. PubMed ID: 36996466
[TBL] [Abstract][Full Text] [Related]
3. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
[TBL] [Abstract][Full Text] [Related]
4. Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy.
Kikushima W; Sakurada Y; Sugiyama A; Tanabe N; Kume A; Iijima H
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):311-316. PubMed ID: 27534663
[TBL] [Abstract][Full Text] [Related]
5. Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.
Wolf S; Bandello F; Loewenstein A; Slakter J; Katz T; Sowade O; Korobelnik JF
Ophthalmologica; 2016; 236(2):95-9. PubMed ID: 27449643
[TBL] [Abstract][Full Text] [Related]
6. How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Empeslidis T; Storey M; Giannopoulos T; Konidaris V; Tranos PG; Panagiotou ES; Voudouragkaki IC; Konstas AG
Adv Ther; 2019 Jul; 36(7):1532-1548. PubMed ID: 31102206
[TBL] [Abstract][Full Text] [Related]
7. OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Khanani AM; Eichenbaum D; Schlottmann PG; Tuomi L; Sarraf D
Retina; 2018 Nov; 38(11):2103-2117. PubMed ID: 29697591
[TBL] [Abstract][Full Text] [Related]
8. Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration.
Cheong KX; Teo KYC; Cheung CMG
Surv Ophthalmol; 2021; 66(1):68-97. PubMed ID: 32428539
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal aflibercept in treatment-resistant pigment epithelial detachment.
Kocak I
Int Ophthalmol; 2017 Jun; 37(3):531-537. PubMed ID: 27444307
[TBL] [Abstract][Full Text] [Related]
10. Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.
Tyagi P; Juma Z; Hor YK; Scott NW; Ionean A; Santiago C
BMC Ophthalmol; 2018 Jun; 18(1):148. PubMed ID: 29929478
[TBL] [Abstract][Full Text] [Related]
11. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration.
Rouvas A; Chatziralli I; Androu A; Mpougatsou P; Alonistiotis D; Douvali M; Kabanarou SA; Theodossiadis P
Int Ophthalmol; 2019 Feb; 39(2):431-440. PubMed ID: 29404860
[TBL] [Abstract][Full Text] [Related]
12. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
[TBL] [Abstract][Full Text] [Related]
13. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
